The Healthcare industry is up 2.9% in the last week, with Caliway Biopharmaceuticals up 8.7%. In contrast, the industry has lost 7.1% in the last 12 months. Earnings are forecast to grow by 45% annually.
Has the Taiwanese Healthcare Sector valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 11 Aug 2025 | NT$1.7t | NT$262.9b | NT$12.7b | 21.5x | 130x | 6.3x |
Wed, 09 Jul 2025 | NT$1.6t | NT$261.0b | NT$16.4b | 20.2x | 95.9x | 6x |
Fri, 06 Jun 2025 | NT$1.6t | NT$260.9b | NT$16.3b | 19.4x | 95.1x | 5.9x |
Sun, 04 May 2025 | NT$1.4t | NT$255.2b | NT$12.4b | 20x | 116.6x | 5.7x |
Tue, 01 Apr 2025 | NT$1.5t | NT$254.0b | NT$11.6b | 20.4x | 128.6x | 5.8x |
Thu, 27 Feb 2025 | NT$1.7t | NT$246.6b | NT$8.4b | 24.2x | 198.4x | 6.8x |
Sat, 25 Jan 2025 | NT$1.5t | NT$246.2b | NT$8.7b | 22.2x | 175.5x | 6.2x |
Mon, 23 Dec 2024 | NT$1.4t | NT$245.0b | NT$8.6b | 21.7x | 167.1x | 5.9x |
Wed, 20 Nov 2024 | NT$1.5t | NT$244.5b | NT$9.0b | 22x | 163.8x | 6x |
Fri, 18 Oct 2024 | NT$1.5t | NT$236.4b | NT$6.8b | 24.8x | 225.9x | 6.5x |
Sun, 15 Sep 2024 | NT$1.6t | NT$236.4b | NT$6.8b | 24.9x | 232.1x | 6.6x |
Tue, 13 Aug 2024 | NT$1.6t | NT$230.0b | NT$3.9b | 26.7x | 403.3x | 6.9x |
Thu, 11 Jul 2024 | NT$1.7t | NT$228.8b | NT$3.6b | 28.1x | 461.6x | 7.2x |
Sat, 08 Jun 2024 | NT$1.5t | NT$228.6b | NT$3.9b | 27.3x | 393.1x | 6.7x |
Mon, 06 May 2024 | NT$1.4t | NT$229.4b | NT$4.5b | 25.5x | 322.8x | 6.3x |
Wed, 03 Apr 2024 | NT$1.5t | NT$228.0b | NT$6.0b | 26.3x | 247.1x | 6.5x |
Fri, 01 Mar 2024 | NT$1.5t | NT$226.7b | NT$6.8b | 25.7x | 218.2x | 6.6x |
Sun, 28 Jan 2024 | NT$1.4t | NT$225.0b | NT$5.9b | 24.8x | 232.9x | 6.2x |
Tue, 26 Dec 2023 | NT$1.4t | NT$224.7b | NT$5.9b | 25.3x | 237.8x | 6.2x |
Thu, 23 Nov 2023 | NT$1.4t | NT$224.6b | NT$6.7b | 24.8x | 206.9x | 6.2x |
Sat, 21 Oct 2023 | NT$1.3t | NT$225.3b | NT$8.3b | 24.2x | 158.3x | 5.8x |
Mon, 18 Sep 2023 | NT$1.4t | NT$225.2b | NT$8.2b | 26.1x | 170.6x | 6.2x |
Wed, 16 Aug 2023 | NT$1.3t | NT$222.1b | NT$7.0b | 24.7x | 191.9x | 6.1x |
Fri, 14 Jul 2023 | NT$1.4t | NT$226.5b | NT$11.6b | 24.9x | 119.6x | 6.1x |
Sun, 11 Jun 2023 | NT$1.4t | NT$225.0b | NT$11.1b | 24.9x | 130x | 6.4x |
Tue, 09 May 2023 | NT$1.5t | NT$220.1b | NT$12.0b | 24.9x | 122x | 6.7x |
Thu, 06 Apr 2023 | NT$1.4t | NT$221.6b | NT$13.1b | 22.1x | 108.8x | 6.4x |
Sat, 04 Mar 2023 | NT$1.4t | NT$215.2b | NT$14.4b | 21.6x | 100.7x | 6.7x |
Mon, 30 Jan 2023 | NT$1.3t | NT$214.5b | NT$13.8b | 20.1x | 94.3x | 6.1x |
Wed, 28 Dec 2022 | NT$1.3t | NT$214.5b | NT$13.8b | 20.1x | 96.6x | 6.2x |
Fri, 25 Nov 2022 | NT$1.3t | NT$214.4b | NT$14.1b | 17.4x | 92.8x | 6.1x |
Sun, 23 Oct 2022 | NT$1.1t | NT$207.4b | NT$10.8b | 18.5x | 103.6x | 5.4x |
Tue, 20 Sep 2022 | NT$1.4t | NT$207.4b | NT$10.8b | 21.1x | 127.7x | 6.6x |
Thu, 18 Aug 2022 | NT$1.3t | NT$208.3b | NT$12.0b | 20.7x | 105.9x | 6.1x |
105.9x
Which industries have driven the changes within the Taiwanese Healthcare sector?
TW Market | 2.50% | |
Healthcare | 2.92% | |
Pharma | 4.77% | |
Biotech | 3.66% | |
Healthcare Services | 1.79% | |
Healthtech | 0.64% | |
Life Sciences | -0.68% | |
Medical Equipment | -1.32% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6919 Caliway Biopharmaceuticals | NT$131.50 | 8.7% +NT$16.3b | 123.6% | PS5040x | |
6949 Pell Bio-Med Technology | NT$339.00 | 59.9% +NT$7.4b | 230.7% | PS744.3x | |
6446 PharmaEssentia | NT$510.00 | 2.7% +NT$4.5b | -25.9% | PE43.6x | |
6472 Bora Pharmaceuticals | NT$717.00 | 4.0% +NT$3.4b | 9.9% | PE17.4x | |
6945 AP Biosciences | NT$137.00 | 31.1% +NT$2.8b | 160.0% | PB7.2x |